MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers

Biliary tract cancers (BTCs) have poor prognosis and limited therapeutic options. The impact of O (6)‐methylguanine‐DNA methyltransferase (MGMT) inactivation in advanced BTC patients is not established. We investigated the prevalence, prognostic, and predictive impact of MGMT inactivation in two mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Niger, Monica, Nichetti, Federico, Casadei‐Gardini, Andrea, Morano, Federica, Pircher, Chiara, Tamborini, Elena, Perrone, Federica, Canale, Matteo, Lipka, Daniel B., Vingiani, Andrea, Agnelli, Luca, Dobberkau, Anna, Hüllein, Jennifer, Korell, Felix, Heilig, Christoph E., Pusceddu, Sara, Corti, Francesca, Droz, Michele, Ulivi, Paola, Prisciandaro, Michele, Antista, Maria, Bini, Marta, Cattaneo, Laura, Milione, Massimo, Glimm, Hanno, Köhler, Bruno C., Pruneri, Giancarlo, Hübschmann, Daniel, Fröhling, Stefan, Mazzaferro, Vincenzo, Pietrantonio, Filippo, Di Bartolomeo, Maria, de Braud, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297767/
https://www.ncbi.nlm.nih.gov/pubmed/35621918
http://dx.doi.org/10.1002/1878-0261.13256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297767/
https://www.ncbi.nlm.nih.gov/pubmed/35621918
http://dx.doi.org/10.1002/1878-0261.13256

Ejemplares similares